BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6552855)

  • 1. Studies on the various causal factors related to hypercoagulability in the field of obstetrics - with special reference to the onset of DIC as viewed from the changing of kinin-kallikrein system and fibrinopeptide A.
    Suzuki S; Murakoshi T; Sakamoto W
    Adv Exp Med Biol; 1983; 156 (Pt B)():1055-65. PubMed ID: 6552855
    [No Abstract]   [Full Text] [Related]  

  • 2. The kinetics of blood coagulability: fibrinolytic and kallikrein-kinin system at the onset and during labor.
    Suzuki S; Sakamoto W
    Eur J Obstet Gynecol Reprod Biol; 1984 May; 17(2-3):209-18. PubMed ID: 6564040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prekallikrein levels during pregnancy.
    Marcel GA; Caspar C; Sabatier C; Gautray J; Schirar A
    Pathol Biol (Paris); 1975 Dec; 23 suppl():66-8. PubMed ID: 772561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the kallikrein-kinin system in Rocky Mountain spotted fever.
    Yamada T; Harber P; Pettit GW; Wing DA; Oster CN
    Ann Intern Med; 1978 Jun; 88(6):764-8. PubMed ID: 307354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The kallikrein-kinin system and disseminated intravascular coagulation].
    Maki M; Hayakawa M
    Rinsho Byori; 1985 Jun; Spec No 63():37-45. PubMed ID: 2413228
    [No Abstract]   [Full Text] [Related]  

  • 6. [Laboratory values of kallikrein-kininogen-kinin].
    Omata K
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():573-6. PubMed ID: 16149580
    [No Abstract]   [Full Text] [Related]  

  • 7. The kinin-forming enzyme system in pregnancy and obstetrical DIC.
    Maki M; Soga K; Gotoh K
    Bibl Haematol; 1983; (49):239-46. PubMed ID: 6421272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Disseminated intravascular coagulation].
    Maekawa T
    Rinsho Byori; 1973 Jan; 21(1):24-30. PubMed ID: 4267649
    [No Abstract]   [Full Text] [Related]  

  • 9. Contact factors in health and disease.
    Saito H
    Semin Thromb Hemost; 1987 Jan; 13(1):36-49. PubMed ID: 3551076
    [No Abstract]   [Full Text] [Related]  

  • 10. Coagulopathies.
    Lewis JH; Spero JA; Hasiba U
    Dis Mon; 1977 Jun; 23(9):1-64. PubMed ID: 326505
    [No Abstract]   [Full Text] [Related]  

  • 11. [Plasma kallikrein-kinin system in hypercoagulable state (author's transl)].
    Koie K; Kamiya T; Takamatsu J; Hayashi K; Saito H
    Rinsho Ketsueki; 1980 Jun; 21(6):704-13. PubMed ID: 6450843
    [No Abstract]   [Full Text] [Related]  

  • 12. Disseminated intravascular coagulation: a reappraisal.
    Colman RW; Robboy SJ; Minna JD
    Annu Rev Med; 1979; 30():359-74. PubMed ID: 400501
    [No Abstract]   [Full Text] [Related]  

  • 13. Analyses of factor XII, prekallikrein and kallikrein inhibitory capacity in patients with laboratory signs of DIC.
    Egberg N; Hellgren M
    Scand J Clin Lab Invest Suppl; 1985; 178():25-9. PubMed ID: 3867118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current views on the relationship of the kallikrein-kinin system to coagulation and fibrinolysis].
    Poucková P
    Cesk Fysiol; 1977; 26(6):549-54. PubMed ID: 342127
    [No Abstract]   [Full Text] [Related]  

  • 15. Kallikrein-kinin system in diabetic patients.
    Uehara S; Isogawa S; Sakamoto W; Hirayama A
    Arzneimittelforschung; 1988 May; 38(5):721-3. PubMed ID: 3415716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma kallikrein-kinin system in nonmammalian blood: evolutionary aspects.
    Seki T; Miwa I; Nakajima T; Erdös EG
    Am J Physiol; 1973 Jun; 224(6):1425-30. PubMed ID: 4197183
    [No Abstract]   [Full Text] [Related]  

  • 17. [DIC (author's transl)].
    Maekawa T; Takeuchi T
    Kokyu To Junkan; 1976 Feb; 24(2):96-104. PubMed ID: 769126
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanism and significance of kinin formation in nephrotic syndrome.
    Nakamura K; Kazama M; Morioka M; Tahara C; Abe T
    Adv Exp Med Biol; 1986; 198 Pt B():253-62. PubMed ID: 3028075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diseases caused by kallikrein-kinin-system deficiencies].
    Ikari N; Kato H
    Nihon Rinsho; 1978 Aug; 36(8):2933-7. PubMed ID: 309519
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies of the activation and inhibition of the plasma kallikrein-kinin system.
    Kaplan AP; Reddigari S; Brunnée T; Nishikawa K; Kuna P; Silverberg M
    Agents Actions Suppl; 1992; 38 ( Pt 3)():317-28. PubMed ID: 1462866
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.